Virogates Products

Virogates Products

suPARnostic® is the only CE-IVD certified product range applied for clinical determination of suPAR in human plasma and serum.

suPAR is a universal and broadly applicable prognostic biomarker of chronic inflammation and immune activation across diseases. suPAR can identify inflammation and immune activation to aid in determining the risk of patient outcomes.

Significant clinical benefits include:

  • Identification of patients who can be safely discharged after treatment
  • Helps to prioritize patients and reduce Emergency Department crowding
  • Add to clinical decisions
  • Identification of high-risk patients with unaffected vital signs

suPARnostic® also improves the efficiency of the Emergency Department by shortening the average patient-length-of-stay, which leads to cost savings.

Project Details

Website:

https://www.virogates.com/

Client Name:

Virogates

suPARnostic® TurbiLatex

suPAR is the soluble form of urokinase Plasminogen Activator Receptor (uPAR). The amount of suPAR is a measure of immune activation and inflammation. suPAR is a biomarker increased by disease presence and severity

Important clinical benefits include;

  • Aid in prioritization of patients who can be discharged after treatment
  • Assistance in the identification of high-risk patients with unaffected vital signs
  • Shortens the average patient-length-of-stay and reduces the cost of healthcare

The suPARnostic® TurbiLatex product is CE-IVD approved and validated on the Roche Diagnostics Cobas c 501/2 and c 701/2 systems, the Siemens Atellica, and ADVIA Chemistry XPT, and the Abbott Architect c and Alinity ci systems.

suPARnostic® Quick Triage

The suPARnostic® Quick Triage kit is used in the Point of Care situation for early warning and patient triaging. The suPARnostic® Quick Triage is an easy-to-use, quantitative test that will allow clinicians and nurses to obtain a fast patient prognosis for patient disease severity, progression and outcome. In addition, test results can quickly be achieved on-site at the Emergency Department, avoiding passing via the core laboratory.

The suPARnostic® Quick Triage test is used together with the aLF reader from Qiagen and delivers:

  • Simple and easy-to-operate test
  • Quick and fully quantitative suPAR results
  • Early results for better triage of patients in Emergency Department settings
suPARnostic® ELISA

The CE/IVD marked suPARnostic® ELISA assay is a full quantifiable method.

The suPARnostic® ELISA assay is based on a simplified double monoclonal antibody sandwich ELISA assay whereby samples and

peroxidase-conjugated anti-suPAR are first mixed and then incubated in anti-suPAR precoated microwells.

The recombinant suPAR standards of the kit are calibrated against healthy human blood donor samples. The suPAR concentrations are determined as ng/mL plasma.

Clinical benefits of ELISA suPARnostic®:

  • Identification of patients who can be safely discharged after treatment
  • Helps to prioritize patients and reduce Emergency Department crowding
  • Add to clinical decisions
  • Identification of high-risk patients with unaffected vital signs
YK-8000F Mini /Transport Patient Monitor
  • Portable,easy to carry
  • 8″LCD display
  • HR/PR, NIBP, RR, ECG, SpO2,TEM.
  • Rechargeable lead-acid batteries
  • English/Chinese Language
  • Main Accessories:5 Lead ECG Cable&Lead wire,Skin Temperature Probe,BCI adult finger clip Spo2 sensor,Adult Blood Pressure Cuff,Ground Cable

Need Any Help!

Hotline
Send Us Email